Track the 명문제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 명문제약 has published 80 public disclosures. Market capitalisation: €42.3bn. The latest transaction was reported on 11 June 2026 (Purchase). Among the most active insiders: 우석민. Every trade is openly available.
77
Insider Decl.
n/a
Thresholds
€11,558
62 ops.
Buy Volume
n/a
n/a
Sell Volume
12Σ signal
Buys €11,558n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,662 of 28,803 companies
37.1
score / 100
Value
40
Quality
34
FCF yld-21%
Earn yld4.7%
EV/EBITDA11.9x
ROE-2.5%
Gross mgn55%
Net mgn1.0%
Debt/EBITDA8.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.